Northland Securities Upgrades Medifast (MED) to Outperform
Tweet
Share
E-mailGet Alerts MED Hot Sheet
Price: $11.48 -0.95%
Rating Summary:
4 Buy, 9 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Rating Summary:
4 Buy, 9 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Join SI Premium – FREE
Northland Securities upgraded Medifast (NYSE: MED) from Market Perform to Outperform with a price target of $29.00 (from $16.00).
For an analyst ratings summary and ratings history on Medifast click here. For more ratings news on Medifast click here.
Shares of Medifast closed at $20.63 yesterday.
For an analyst ratings summary and ratings history on Medifast click here. For more ratings news on Medifast click here.
Shares of Medifast closed at $20.63 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Northland Upgrades Hyliion Holdings (HYLN) to Outperform 'on Improved Visibility to KARNO Commercialization'
- Citi upgrades Establishment Labs to Buy with $92 target
- Wolfe Research Upgrades Biogen (BIIB) to Outperform
Create E-mail Alert Related Categories
UpgradesRelated Entities
Northland SecuritiesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
